Double LVIS stent intussusception assisted coils embolization in treatment of intracranial blood blister-like aneurysm
10.13929/j.issn.1672-8475.2020.09.005
- VernacularTitle: 双LVIS支架套叠辅助弹簧圈栓塞治疗颅内血泡样动脉瘤
- Author:
Chao LYU
1
Author Information
1. Department of Neurosurgery, Xijing Hospital of Airforce Medical University
- Publication Type:Journal Article
- Keywords:
Cerebral angiography;
Embolization, therapeutic;
Intracranial aneurysm;
Stents
- From:
Chinese Journal of Interventional Imaging and Therapy
2020;17(9):533-537
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To observe the effect of double LVIS stent intussusception assisted coils embolization in treatment of intracranial blood blister-like aneurysm (BBA). Methods: Data of 45 patients with BBA and treated by stent-assisted coils embolization were retrospectively analyzed. The patients were divided into double LVIS stent group (DLS group, 18 cases) and non-double LVIS stent group (NDLS group, 27 cases) according to the disparate therapy method. The operation outcomes, perioperative complications and follow-up results were compared between groups. Results: The immediately completely embolization rate in DLS group was 72.22% (13/18), in NDLS group was 55.56% (15/27), and the perioperative complications rate in DLS group was 16.67%(3/18), in NDLS group was 25.93%(7/27) (both P>0.05). No significant difference of the immediately completely embolization rate nor of perioperative complications rate was found between 2 groups (both P>0.05). At the 3- and 6-month follow-up, no significant difference of neurological recovery outcomes post operation was found between 2 groups (both P>0.05). The aneurysm recurrence rate in DLS group was 15.38% (2/13), lower than that in NDLS group (57.89%, 11/19) at 3-month follow-up (P=0.03). No significant difference of aneurysm recurrence rate at 6-month follow-up was found between groups (0 vs 13.33%, P>0.05). Conclusion: Double LVIS stent intussusception assisted coils embolization is safe and effective for treatment of BBA, which can significantly reduce 3-month aneurysm recurrence rate.
